Millie
your market intelligence analyst
Search Results
52 results
Your search is now limited to «Clinical Trials» expert search.
PR Newswire 12/12/2019 15:46
The analysis is based on data from more than 530 patients from three previously published trials: a European phase III trial, a Swedish phase II trial and a US phase II trial.
More from PR Newswire:
ClinicalTrials.gov 12/09/2019 09:21
This clinical trial is proposed as an interdisciplinary study that can contribute to the characterization of the efficacy of treatment with probiotics in patients with T2DM of different stages of evolution, without and with hepatic involvement.
More from ClinicalTrials.gov:
Business Wire 12/09/2019 07:00
The KVD001 Phase 2 clinical trial study was designed to evaluate patients who were poor responders to previous treatment with anti-VEGF therapy.
More from Business Wire:
GlobeNewswire 12/06/2019 07:00
The preclinical pipeline also includes AT-003, an ARI designed to cross through the back of the eye when dosed orally, for the treatment of diabetic retinopathy, expected to advance into a Phase 1 study in 2020.
More from GlobeNewswire:
FeedNavigator (EU) 12/05/2019 19:55
The AAT intervention showed promise in the subgroup of adolescents with recent-onset type 1 diabetes.
More from FeedNavigator (EU):
American Diabetes Journals 11/20/2019 15:00
The trial protocol was approved by all relevant institutional review boards/independent ethics committees, and the trial was conducted in accordance with ICH Good Clinical Practice guidelines and the Declaration of Helsinki.
More from American Diabetes Journals:
Healio News 11/20/2019 12:07
Oral insulin demonstrates safety, efficacy in phase 2b trial Adults with type 2 diabetes assigned an oral formulation of human insulin achieved a clinically meaningful reduction in HbA1c compared with those assigned placebo, according to a press release from Oramed Pharmaceuticals ...
More from Healio News:
Benzinga 10/30/2019 07:31
These programs include olinciguat in Phase 2 development for sickle cell disease, IW-6463 in Phase 1 development for serious and orphan central nervous system diseases, and two preclinical programs targeting serious liver and lung diseases, respectively.
More from Benzinga:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications